Citigroup’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $87.7K | Sell |
14,009
-18,856
| -57% | -$118K | ﹤0.01% | 3741 |
|
|
2025
Q1 | $193K | Sell |
32,865
-2,876
| -8% | -$16.9K | ﹤0.01% | 3465 |
|
|
2024
Q4 | $294K | Buy |
35,741
+1,841
| +5% | +$15.1K | ﹤0.01% | 3342 |
|
|
2024
Q3 | $302K | Buy |
33,900
+23,488
| +226% | +$209K | ﹤0.01% | 3323 |
|
|
2024
Q2 | $78.7K | Buy |
10,412
+3,727
| +56% | +$28.2K | ﹤0.01% | 3605 |
|
|
2024
Q1 | $52.5K | Buy |
6,685
+2,669
| +66% | +$21K | ﹤0.01% | 3855 |
|
|
2023
Q4 | $35.6K | Sell |
4,016
-102,410
| -96% | -$907K | ﹤0.01% | 3951 |
|
|
2023
Q3 | $955K | Sell |
106,426
-42,070
| -28% | -$377K | ﹤0.01% | 1948 |
|
|
2023
Q2 | $1.83M | Sell |
148,496
-367,546
| -71% | -$4.54M | ﹤0.01% | 1765 |
|
|
2023
Q1 | $4.79M | Buy |
516,042
+370,338
| +254% | +$3.44M | ﹤0.01% | 1137 |
|
|
2022
Q4 | $1.53M | Sell |
145,704
-4,036
| -3% | -$42.4K | ﹤0.01% | 1706 |
|
|
2022
Q3 | $2.71M | Buy |
149,740
+26,552
| +22% | +$481K | ﹤0.01% | 1418 |
|
|
2022
Q2 | $1.75M | Buy |
123,188
+122,969
| +56,150% | +$1.74M | ﹤0.01% | 1670 |
|
|
2022
Q1 | $5K | Sell |
219
-1,586
| -88% | -$36.2K | ﹤0.01% | 4976 |
|
|
2021
Q4 | $31K | Buy |
+1,805
| New | +$31K | ﹤0.01% | 4483 |
|